LIFEMD, INC. Deferred Revenue Recognized
LIFEMD, INC. (LFMD) reported Deferred Revenue Recognized of $45.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-05
- LIFEMD, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $45.99M, a 4.20% decline year-over-year.
- LIFEMD, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $49.47M, a 2.71% decline year-over-year.
- LIFEMD, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $58.79M, a 11.79% increase year-over-year.
- LIFEMD, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $48.00M, a 1.01% decline year-over-year.
- LIFEMD, INC. contract with customer, liability, revenue recognized for fiscal 2025 was $192.18M, a 27.65% increase from fiscal 2024.
- LIFEMD, INC. contract with customer, liability, revenue recognized for fiscal 2024 was $150.55M, a 173.54% increase from fiscal 2023.
- LIFEMD, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $55.04M, a 64.97% increase from fiscal 2022.
- LIFEMD, INC. contract with customer, liability, revenue recognized for fiscal 2022 was $33.36M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $45.99M 10-Q · filed 2026-08-05 | $95.46M 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | $49.47M 10-Q · filed 2026-05-06 | |||||||
| 2025-12-31 | $192.18M 10-K · filed 2026-03-10 | |||||||
| 2025-09-30 | $58.79M 10-Q · filed 2025-11-17 | $183.78M 10-Q · filed 2025-11-17 | ||||||
| 2025-06-30 | $48.00M 10-Q · filed 2026-08-05 | $58.68M 10-Q · filed 2025-08-05 | $98.06M 10-Q · filed 2026-08-05 | $123.21M 10-Q · filed 2025-08-05 | ||||
| 2025-03-31 | $50.85M 10-Q · filed 2026-05-06 | $64.52M 10-Q · filed 2025-05-06 | ||||||
| 2024-12-31 | $150.55M 10-K · filed 2026-03-10 | $208.65M 10-K · filed 2025-03-11 | ||||||
| 2024-09-30 | $52.59M 10-Q · filed 2025-11-17 | $48.71M 10-Q · filed 2024-11-07 | $141.44M 10-Q · filed 2025-11-17 | $137.42M 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | $48.49M 10-Q · filed 2025-08-05 | $88.71M 10-Q · filed 2025-08-05 | ||||||
| 2024-03-31 | $13.40M 10-Q · filed 2025-05-06 | |||||||
| 2023-12-31 | $55.04M 10-K · filed 2025-03-11 | |||||||
| 2023-09-30 | $37.76M 10-Q · filed 2024-11-07 | $14.20M 10-Q · filed 2023-11-08 | $102.61M 10-Q · filed 2024-11-07 | $41.63M 10-Q · filed 2023-11-08 | ||||
| 2023-06-30 | $33.99M 10-Q · filed 2024-08-07 | $64.85M 10-Q · filed 2024-08-07 | ||||||
| 2023-03-31 | $12.89M 10-Q · filed 2024-05-08 | |||||||
| 2022-12-31 | $33.36M 10-K · filed 2024-03-11 | |||||||
| 2022-09-30 | $8.99M 10-Q · filed 2023-11-08 | $22.71M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |